Author

Rebecca Friedrich

Institutions: Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin

Observed institutions: Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin

OpenAlex ID: A5115902841

Lung tumouroids as a testing platform for precision CAR T cell therapy

2026 · Lukas Ehlen, Martí Farrera-Sal, et al. · Nature Biomedical Engineering · 5

Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

2026 · Samira Picht, Martí Farrera-Sal, et al. · Molecular Therapy — Nucleic Acids · 4

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation

2026 · Ghazaleh Zarrinrad, Lisa-Marie Burkhardt, et al. · Molecular Therapy Advances · 2

Clinical development of gene edited tacrolimus-resistant Treg (FKBP12 KO -Treg) to enable simultaneous immunosuppression and support of immune regulation

2025 · Ghazaleh Zarrinrad, Lisa-Marie Burkhardt, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 4

Citation count: 11

H-index: 2

I10-index: